These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6018366)

  • 21. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic encephalopathy].
    Rózga J; Szczerbań J
    Pol Tyg Lek; 1980 Jan; 35(4):117-20. PubMed ID: 7053045
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatic encephalopathy. The Danish Society of Hepatology].
    Sørensen M; Vilstrup H; Keiding S; Ott P;
    Ugeskr Laeger; 2007 Mar; 169(12):1106. PubMed ID: 17394817
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimation of protein intake using urinary urea nitrogen in patients with liver cirrhosis.
    Kida Y
    Scand J Gastroenterol; 2009; 44(5):615-8. PubMed ID: 19137458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
    [No Abstract]   [Full Text] [Related]  

  • 27. Determinants of ureagenesis, with particular reference to renal failure.
    Walser M
    Kidney Int; 1980 Jun; 17(6):709-21. PubMed ID: 6997590
    [No Abstract]   [Full Text] [Related]  

  • 28. Adaptive cytoprotection by ammonia and urea-urease system in the rat gastric mucosa.
    Brzozowski T; Konturek P; Sliwowski Z; Szlachcic A; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 1995 Dec; 46(4):471-88. PubMed ID: 8770791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro study of urease/AlaDH enzyme system encapsulated into human erythrocytes and research into its medical applications.
    Hamarat Baysal S; Uslan AH
    Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):71-7. PubMed ID: 12000228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic depuration with heterologous liver. Physiopathological presuppositions, indications and metabolic and hemodynamic characteristics of the experimental preparation].
    Rossotto P; Motta G; Guberti A; Azzena GF; Tabone E
    Minerva Med; 1969 Mar; 60(24):1075-94. PubMed ID: 5781337
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of the metabolic complications of liver cirrhosis on dietary intake.
    Tözün N
    Med Sci Monit; 2000; 6(6):1223-6. PubMed ID: 11208483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tryptophan in hepatic encephalopathy].
    Esquivel López A; Austria Mireles R; Coronado Perdomo D
    Rev Gastroenterol Mex; 1983; 48(2):91-4. PubMed ID: 6622904
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients.
    Zullo A; Rinaldi V; Folino S; Diana F; Attili AF
    Am J Gastroenterol; 1998 May; 93(5):851-2. PubMed ID: 9625155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of parenteral amino acid administration on the brain function and the serum aminogram of patients with liver cirrhosis].
    Leweling H; Knauff HG; Nitschke J; Paquet KJ
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):88-94. PubMed ID: 6776054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Zinc deficiency in liver cirrhosis: a curiosity or a problem?].
    Marchetti P; Amodio P; Caregaro L; Gatta A
    Ann Ital Med Int; 1998; 13(3):157-62. PubMed ID: 9859572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abstracts of the 6th International Symposium on Ammonia--Advances in Hepatic Encephalopathy and Urea Cycle Diseases. The Netherlands, 27-29 April, 1987.
    J Hepatol; 1987; 4 Suppl 1():S1-53. PubMed ID: 3571938
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of aminoacid and protein metabolism disturbances in liver disease (author's transl)].
    Gerok W
    Leber Magen Darm; 1981 Apr; 11(2):63-72. PubMed ID: 6785546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.